Moderna Inc DRC (MRNAm)

Currency in ARS
2,160.00
+90.00(+4.35%)
Closed·
MRNAm Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MRNAm is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,095.002,170.00
52 wk Range
1,380.008,910.00
Key Statistics
Bid/Ask
2,160.00 / 2,175.00
Prev. Close
2,160
Open
2,160
Day's Range
2,095-2,170
52 wk Range
1,380-8,910
Volume
15.72K
Average Volume (3m)
74.92K
1-Year Change
-74.91%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MRNAm Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Moderna Inc DRC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Moderna Inc DRC Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Employees
5800
Market
Argentina

Compare MRNAm to Peers and Sector

Metrics to compare
MRNAm
Peers
Sector
Relationship
P/E Ratio
−3.6x2.6x−0.5x
PEG Ratio
−0.08−0.040.00
Price/Book
1.2x1.8x2.6x
Price / LTM Sales
3.8x3.5x3.2x
Upside (Analyst Target)
-123.6%42.7%
Fair Value Upside
Unlock−5.6%5.8%Unlock

Earnings

Latest Release
May 01, 2025
EPS / Forecast
-2.52 / --
Revenue / Forecast
108.00M / --
EPS Revisions
Last 90 days

MRNAm Income Statement

People Also Watch

8,940.00
ABEVm
-1.32%
61,650.00
ERJm
-2.07%
62,700.00
PLTRm
-3.46%
48.68
ERJ
-0.59%
18,125.00
VISTm
-2.42%

FAQ

What Stock Exchange Does Moderna DRC Trade On?

Moderna DRC is listed and trades on the Buenos Aires Stock Exchange stock exchange.

What Is the Stock Symbol for Moderna DRC?

The stock symbol for Moderna DRC is "MRNAm."

What Is the Moderna DRC Market Cap?

As of today, Moderna DRC market cap is 15.89T.

What Is Moderna DRC's Earnings Per Share (TTM)?

The Moderna DRC EPS (TTM) is -8.72.

From a Technical Analysis Perspective, Is MRNAm a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Moderna DRC Stock Split?

Moderna DRC has split 0 times.

How Many Employees Does Moderna DRC Have?

Moderna DRC has 5800 employees.

What is the current trading status of Moderna DRC (MRNAm)?

As of 23 Jul 2025, Moderna DRC (MRNAm) is trading at a price of 2,160.00, with a previous close of 2,160.00. The stock has fluctuated within a day range of 2,095.00 to 2,170.00, while its 52-week range spans from 1,380.00 to 8,910.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.